Rachael. A. Lee

Rachael. A. Lee

Auto-generated profile, based on publicly available information

Rachael. A. Lee

Division of Infectious Diseases, Department of Medicine, UAB School of Medicine , Birmingham, Alabama

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2021 in The American Journal of Medicine
Verified
Journal Article
Closed access
NWNoah Wald-Dickler
Noah Wald-Dickler
PHPaul D. Holtom
Paul D. Holtom
MPMatthew C. Phillips
Matthew C. Phillips
RCRobert M. Centor
Robert M. Centor
RLRachael. A. Lee
Rachael. A. Lee
BSBrad Spellberg
Brad Spellberg

4 November 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ZNZachary Nelson
Zachary Nelson
AAAbdullah Tarik Aslan
Abdullah Tarik Aslan
NBNathan P Beahm
Nathan P Beahm
MBMichelle D Blyth
Michelle D Blyth
MCMatthew Cappiello
Matthew Cappiello
ALAlfredo J. Mena Lora
Alfredo J. Mena Lora
Importance: Traditional approaches to practice guidelines frequently result in dissociation between strength of recommendation and quality of evidence. Objective: To create a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation strength. Evidence Review: This consensus statement and systematic review applied an approach previously established by the WikiGuidelines Group to construct collaborative clinical guidelines. In May 2023, new and existing members were solicited for questions on urinary tract infection prevention, diagnosis, and management. For each topic, literature searches were conducted up until early 2024 in any language. Evidence was reported according to the WikiGuidelines charter: clear recommendations were established only when reproducible, prospective, controlled studies provided hypothesis-confirming evidence. In the absence of such data, clinical reviews were developed discussing the available literature and associated risks and benefits of various approaches. Findings: A total of 54 members representing 12 countries reviewed 914 articles and submitted information relevant to 5 sections: prophylaxis and prevention (7 questions), diagnosis and diagnostic stewardship (7 questions), empirical treatment (3 questions), definitive treatment and antimicrobial stewardship (10 questions), and special populations and genitourinary syndromes (10 questions). Of 37 unique questions, a clear recommendation could be provided for 6 questions. In 3 of the remaining questions, a clear recommendation could only be provided for certain aspects of the question. Clinical reviews were generated for the remaining questions and aspects of questions not meeting criteria for a clear recommendation. Conclusions and Relevance: In this consensus statement that applied the WikiGuidelines method for clinical guideline development, the majority of topics relating to prevention, diagnosis, and treatment of urinary tract infections lack high-quality prospective data and clear recommendations could not be made. Randomized clinical trials are underway to address some of these gaps; however further research is of utmost importance to inform true evidence-based, rather than eminence-based practice.

1 June 2021 in Annals of Internal Medicine
Verified
Journal Article
Open access
RLRachael A. Lee
Rachael A. Lee
RCRobert M. Centor
Robert M. Centor
LHLinda L. Humphrey
Linda L. Humphrey
JJJanet A. Jokela
Janet A. Jokela
RARebecca Andrews
Rebecca Andrews
AQAmir Qaseem
Amir Qaseem
This ACP guideline describes best practices for prescribing appropriate and short-duration antibiotic therapy for patients presenting with acute bronchitis with chronic obstructive pulmonary diseas... Description: Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with ...

1 March 2020 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
EEEllen F Eaton
Ellen F Eaton
AWAndrew O Westfall
Andrew O Westfall
BMBrandi McClesky
Brandi McClesky
CPCayce S Paddock
Cayce S Paddock
PLPeter S Lane
Peter S Lane
RLRachael A Lee
Rachael A Lee
Hospitalized persons who inject drugs are at a greater risk of adverse hospital outcomes including discharge against medical advice, inpatient illicit drug use, overdose, and death. However, there are limited data on the frequency and outcomes of these events in the United States. This retrospective analysis included patients with injection-related infections receiving a protocol for injection drug use (IDU) at University of Alabama at Birmingham Hospital from 2016 to 2017. In-hospital IDU was suspected or reported drug usage plus confirmatory drug screen, and documented discharges “against medical advice” were deemed patient-directed discharges (PDD). We analyzed the frequency of and associations between in-hospital IDU, PDD, 30-day readmission, and deaths (between 2016 and 2019) using McNemar’s tests. Logistic regression models evaluated the association between PDD, in-hospital IDU, readmission, and death. Overall, 83 patients met inclusion criteria: 28 (34%) with in-hospital IDU, 12 (14%) PDD, 9 (11%) died, and 12 (14%) 30-day readmission. In-hospital IDU was significantly associated with PDD (P = .003), 30-day readmission (P = .005), and death (P = .0003). Patient-directed discharges and 30-day readmission were not significantly associated with death nor with each other. In a cohort of patients receiving inpatient care for injection-related infections, illicit drug use, PDD, 30-day readmissions, and death were common. Furthermore, patients who use illicit drugs while hospitalized are significantly more likely to leave early, be readmitted, and/or die. We must design models of care that prevent adverse outcomes, including drug use and PDD, to reduce barriers to evidence-based treatment of infections.

6 September 2022 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
RLRachael A. Lee
Rachael A. Lee
JSJoshua T. Stripling
Joshua T. Stripling
BSBrad Spellberg
Brad Spellberg
RCRobert M. Centor
Robert M. Centor

3 October 2018 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
RLRachael A Lee
Rachael A Lee
JZJoanna Zurko
Joanna Zurko
BCBernard C Camins
Bernard C Camins
RGRussell L Griffin
Russell L Griffin
JRJ Martin Rodriguez
J Martin Rodriguez
PPPeter G Pappas
Peter G Pappas
Candidemia has a high attributable mortality. The objective of this study was to determine the impact of infectious disease consultation on mortality and clinical outcomes in candidemia. Infectious disease consultation was associated with better adherence to guidelines and improved survival, even in patients with high Acute Physiology and Chronic Health Evaluation II scores.